Brief: Bone Therapeutics Announces Results Of First Efficacy Study Of JTA-004

Biosenic SA

17/10/2018 17:17

Oct 17 (Reuters) - BONE THERAPEUTICS SA  BOTHE.BR :
    * REG-BONE THERAPEUTICS ANNOUNCES SINGLE INTRA-ARTICULAR
INJECTION
OF VISCOSUPPLEMENT JTA-004 DELIVERED HIGHER PAIN REDUCTION THAN
REFERENCE IN FIRST STUDY IN KNEE OSTEOARTHRITIS

Source text for Eikon:  ID:nGNE9w4c1v 
Further company coverage:  BOTHE.BR 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))